Plunkett Research Online: Ultragenyx Pharmaceutical Inc

ULTRAGENYX PHARMACEUTICAL INC (RARE:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ultragenyx Pharmaceuticals is a biotechnology company, focused on the identification, development, and commercialization of products that treat genetic diseases. The business focuses on treating ultra-rare and debilitating diseases. The company develops biologic candidates. One example of Ultragenyx.....



Ultragenyx Pharmaceutical Inc
Ticker: RARE
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 415 483-8800
Fax: 415 483-8810
Address: 60 Leveroni Court
Novato, CA 94949 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Emil KakkisCEO/Director/President/Founder
Shalini SharpCFO/Executive VP
See More
Ultragenyx Pharmaceuticals is a biotechnology company, focused on the identification, development, and commercialization of products that treat genetic diseases. The business focuses on treating ultra-rare and debilitating diseases. The company develops biologic candidates. One example of Ultragenyx.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: